| Website | karustherapeutics... |
| Category | BioTech |
| Phone | 44-(0)2380-111-360 |
| Employees | |
| Founded | 2005 |
| TOTAL | $7.6M |
| FUNDING TOTAL | $7.6M |
| Series B, 9/12 SV Life Sciences New Leaf Venture Partners Novo A/S International Biotechnology Trust | $7.6M |
Karus is an emerging pharmaceutical company whose R&D activities are focused on the design and development of innovative, molecular-targeted, small molecule drugs to treat immune/inflammatory disorders and cancer.
